An Open Label Study of Itacitinib Administered Orally in Patients With Myelofibrosis
Clinical trial NCT01633372 · COMPLETED
Trial details
- NCT number
- NCT01633372
- Sponsor
- Incyte Corporation
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-07-16
- Primary completion
- 2013-12-31
- Enrollment
- 87
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.